Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Bank of Hawaii
BOH
$3.17B
| $34.9M | 0.02% |
441,855
+296,779
| +205% | +$24.6M |
|
677
Celanese
CE
$4.87B
| $34.8M | 0.02% |
305,324
-140,017
| -31% | -$16.1M |
|
678
AngioDynamics
ANGO
$565M
| $34.7M | 0.02% |
1,597,210
-205,684
| -11% | -$4.57M |
|
|
CXO
679
DELISTED
CONCHO RESOURCES INC.
CXO
| $34.7M | 0.02% |
226,915
-38,264
| -14% | -$5.4M |
|
|
WCG
680
DELISTED
Wellcare Health Plans, Inc.
WCG
| $34.6M | 0.02% |
107,970
+30,260
| +39% | +$8.59M |
|
681
Acushnet Holdings
GOLF
$6.08B
| $34.4M | 0.02% |
1,254,055
-4,680
| -0.4% | -$122K |
|
682
Commercial Metals
CMC
$7.53B
| $34.3M | 0.02% |
1,673,609
+160,565
| +11% | +$3.46M |
|
683
CGI
GIB
$14.5B
| $34.3M | 0.02% |
532,871
+305,959
| +135% | +$19.9M |
|
684
WisdomTree
WT
$3.01B
| $34.2M | 0.02% |
4,030,023
-1,813,615
| -31% | -$15.4M |
|
685
Digimarc Corp
DMRC
$137M
| $34.1M | 0.02% |
1,083,953
+165,356
| +18% | +$4.86M |
|
686
WaFd
WAFD
$2.69B
| $33.8M | 0.02% |
1,055,034
+392,860
| +59% | +$13.2M |
|
687
Monolithic Power Systems
MPWR
$65.8B
| $33.5M | 0.02% |
267,108
-1,584
| -0.6% | -$221K |
|
|
NBIS
688
Nebius Group N.V.
NBIS
$47.7B
| $33.4M | 0.02% |
1,016,443
+223,760
| +28% | +$7.57M |
|
689
Invesco QQQ Trust
QQQ
$449B
| $33.4M | 0.02% |
179,798
+5,098
| +3% | +$922K |
|
690
Grand Canyon Education
LOPE
$3.84B
| $33.4M | 0.02% |
295,889
+88,622
| +43% | +$10.3M |
|
691
Supernus Pharmaceuticals
SUPN
$2.73B
| $33.2M | 0.02% |
659,330
-6,062
| -0.9% | -$299K |
|
692
Assembly Biosciences
ASMB
$513M
| $33.1M | 0.02% |
74,350
+7,231
| +11% | +$3.39M |
|
693
Credicorp
BAP
$31.1B
| $32.8M | 0.02% |
147,015
+19,592
| +15% | +$4.38M |
|
694
Snap-on
SNA
$21.1B
| $32.6M | 0.02% |
177,470
-19,184
| -10% | -$3.34M |
|
|
GWR
695
DELISTED
Genesee & Wyoming Inc.
GWR
| $32.4M | 0.02% |
356,195
+482
| +0.1% | +$41.8K |
|
696
Henry Schein
HSIC
$9.64B
| $31.8M | 0.02% |
477,276
-3,577,687
| -88% | -$223M |
|
697
Advanced Energy
AEIS
$11.7B
| $31.8M | 0.02% |
614,930
+290,020
| +89% | +$16.8M |
|
698
1st Source
SRCE
$2.09B
| $31.6M | 0.02% |
599,888
-8,536
| -1% | -$476K |
|
699
Digital Realty Trust
DLR
$72.4B
| $31.5M | 0.02% |
280,116
-47,307
| -14% | -$5.66M |
|
|
ECYT
700
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $31.2M | 0.02% |
+1,758,435
| New | +$30.2M |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.